These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1700 related items for PubMed ID: 25877610

  • 1. [Outcomes and prognostic factors of distant metastasis in patients with advanced cervical squamous cell carcinoma treated with concurrent chemoradiotherapy].
    Ma R, Zhang H, Zou L, Qu Y.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):125-30. PubMed ID: 25877610
    [Abstract] [Full Text] [Related]

  • 2. Predictive factor of distant recurrence in locally advanced squamous cell carcinoma of the cervix treated with concurrent chemoradiotherapy.
    Hirakawa M, Nagai Y, Inamine M, Kamiyama K, Ogawa K, Toita T, Murayama S, Aoki Y.
    Gynecol Oncol; 2008 Jan; 108(1):126-9. PubMed ID: 17936344
    [Abstract] [Full Text] [Related]

  • 3. [Significance and implication on changes of serum squamous cell carcinoma antigen in the diagnosis of recurrence squamous cell carcinoma of cervix].
    Li Q, Liu S, Liu H, Zhang J, Guo S, Wang L.
    Zhonghua Fu Chan Ke Za Zhi; 2015 Feb; 50(2):131-6. PubMed ID: 25877611
    [Abstract] [Full Text] [Related]

  • 4. [Clinical significance of serum squamous cell carcinoma antigen in patients with early cervical squamous cell carcinoma].
    Li D, Xu XX, Yan DD, Yuan SH, Lou HM.
    Zhonghua Zhong Liu Za Zhi; 2019 May 23; 41(5):357-362. PubMed ID: 31137169
    [Abstract] [Full Text] [Related]

  • 5. Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma.
    Duk JM, Groenier KH, de Bruijn HW, Hollema H, ten Hoor KA, van der Zee AG, Aalders JG.
    J Clin Oncol; 1996 Jan 23; 14(1):111-8. PubMed ID: 8558185
    [Abstract] [Full Text] [Related]

  • 6. Prognostic value of pretreatment carcinoembryonic antigen after definitive radiotherapy with or without concurrent chemotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY, Hsu HC, Sun LM, Chanchien CC, Lin H, Chen HC, Tseng CW, Ou YC, Chang HY, Fang FM, Huang YJ, Wang CY, Lu HM, Tsai CC, Ma YY, Fu HC, Wang YM, Wang CJ.
    Int J Radiat Oncol Biol Phys; 2011 Nov 15; 81(4):1105-13. PubMed ID: 20932670
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Outcomes and prognostic factors of advanced squamous cervical cancer after concurrent chemoradiotherapy].
    Binbin T, Lingying W, Manni H, Jusheng A, Ning L.
    Zhonghua Fu Chan Ke Za Zhi; 2014 May 15; 49(5):348-54. PubMed ID: 25030731
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The Prognosis and Risk Stratification Based on Pelvic Lymph Node Characteristics in Patients With Locally Advanced Cervical Squamous Cell Carcinoma Treated With Concurrent Chemoradiotherapy.
    Li X, Wei LC, Zhang Y, Zhao LN, Li WW, Ping LJ, Dang YZ, Hu J, Shi M.
    Int J Gynecol Cancer; 2016 Oct 15; 26(8):1472-9. PubMed ID: 27400321
    [Abstract] [Full Text] [Related]

  • 11. Pretreatment carcinoembryonic antigen level is a risk factor for para-aortic lymph node recurrence in addition to squamous cell carcinoma antigen following definitive concurrent chemoradiotherapy for squamous cell carcinoma of the uterine cervix.
    Huang EY, Huang YJ, Chanchien CC, Lin H, Wang CJ, Sun LM, Tseng CW, Tsai CC, Ou YC, Fu HC, Chen HC, Hsu HC, Wang CY.
    Radiat Oncol; 2012 Jan 30; 7():13. PubMed ID: 22289572
    [Abstract] [Full Text] [Related]

  • 12. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC, Wang L, Lin JC, Jan JS.
    J Formos Med Assoc; 2015 Mar 30; 114(3):231-7. PubMed ID: 25777974
    [Abstract] [Full Text] [Related]

  • 13. Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.
    Choi KH, Lee SW, Yu M, Jeong S, Lee JW, Lee JH.
    J Gynecol Oncol; 2019 Jan 30; 30(1):e1. PubMed ID: 30479085
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Correlation of serum squamous cell carcinoma antigen with clinico-pathological features and prognosis of squamous cell carcinoma of uterine cervix].
    Xiong Y, Liang LZ, Zheng M, Wei M, Shen Y.
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan 30; 42(1):29-33. PubMed ID: 17331418
    [Abstract] [Full Text] [Related]

  • 16. Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2-IVA cervical cancer and its clinical prognostic factors.
    Fujiwara M, Isohashi F, Mabuchi S, Yoshioka Y, Seo Y, Suzuki O, Sumida I, Hayashi K, Kimura T, Ogawa K.
    J Radiat Res; 2015 Mar 30; 56(2):305-14. PubMed ID: 25428244
    [Abstract] [Full Text] [Related]

  • 17. Risk stratification of patients with advanced squamous cell carcinoma of cervix treated by radiotherapy alone.
    Hong JH, Tsai CS, Lai CH, Chang TC, Wang CC, Chou HH, Lee SP, Lee CC, Tang SG, Hsueh S.
    Int J Radiat Oncol Biol Phys; 2005 Oct 01; 63(2):492-9. PubMed ID: 15925454
    [Abstract] [Full Text] [Related]

  • 18. Maximum Standardized Uptake Value of Pelvic Lymph Nodes in [18F]-Fluorodeoxyglucose Positron Emission Tomography Is a Prognostic Factor for Para-Aortic Lymph Node Recurrence in Pelvic Node-Positive Cervical Cancer Treated With Definitive Chemoradiotherapy.
    Kim DH, Kim WT, Bae JS, Ki YK, Park D, Suh DS, Kim KH, Lee JH, Lee JY, Jeon HS, Nam JH.
    Int J Gynecol Cancer; 2016 Sep 01; 26(7):1274-80. PubMed ID: 27465890
    [Abstract] [Full Text] [Related]

  • 19. Tumor invasion depth is a useful pathologic assessment for predicting outcomes in cervical squamous cell carcinoma after neoadjuvant radiotherapy.
    Lv Y, Wang N, Liu Y, Li X, Fan L, Li M, Wang L, Yu Z, Yan Q, Guo Y, Guo S, Wei L, Shi M, Wang Z.
    Diagn Pathol; 2015 Nov 04; 10():200. PubMed ID: 26537362
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 85.